Aaron Iding and Colleagues on Additional Oxerutin Link to DVT
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”Additional oxerutin therapy to promote deep vein thrombus resolution (RESOLVE-DVT): a randomized controlled pilot trial
Oxerutin therapy alongside standard treatment reduced residual venous obstruction in deep vein thrombosis patients, potentially lowering postthrombotic syndrome risk compared to standard treatment alone.
Authors: Aaron Iding, Ruben Hupperetz, Rutger Brans, Hugo Ten cate, Daan van Twist, Arina J. Ten Cate-Hoek”
Read the full article here.
Article: Additional oxerutin therapy to promote deep vein thrombus resolution (RESOLVE-DVT): a randomized controlled pilot trial
Authors: Aaron Iding, Ruben D. Hupperetz, Rutger J. B. Brans, Hugo ten Cate, Daan J. L. van Twist, Arina J. ten Cate-Hoek
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 14, 2026, 09:32Kalyan Roy: Swirling as a Simple Indicator of Platelet Quality
-
Apr 14, 2026, 09:26Kausik Ray: How Physicians and Patients Perceive Risk in Lipid Modification Therapy
-
Apr 14, 2026, 09:14Hossam Qassem: When To Start Anticoagulation After Cerebral Aneurysm Clipping
-
Apr 14, 2026, 09:09Kevin Land: Near Elimination of Vaso-Occlusive Crises in Sickle Cell Disease
-
Apr 14, 2026, 07:58Anton Ilich։ A New Test for Rapid Detection of Fibrinolysis in Postpartum Hemorrhage
-
Apr 13, 2026, 17:41Peter Zdziarski: Glanzmann’s Research Foundation Listed as GT Patient Organization on NORD
-
Apr 13, 2026, 17:39Nathan Connell: Why Prophylaxis in vWD Has Historically Lagged Behind Established Practice in Hemophilia
-
Apr 13, 2026, 17:38Tareq Abadl: A Blood Transfusion Can Cause a Delayed Platelet Crash
-
Apr 13, 2026, 13:33Tetsumei Urano: Join for the ISTH Educational Programs at APSTH 2026 in Japan